Perrigo Company plc has announced it has received final approval from the U.S. Food and Drug Administration for its AB r...
The REGAIN consortium, led by Audion Therapeutics BV, a company dedicated to the development of therapeutics for he...
SOTIO, a biotechnology company owned by PPF Group, announces the appointment of Harald Fricke, M.D., Ph.D. as Chief Medi...
The U.S. Food and Drug Administration (FDA) has approved Cablivi (caplacizumab-yhdp) in combination with plasma exc...
Merck KGaA, Darmstadt, Germany, which operates its biopharmaceutical business as EMD Serono in the U.S. and Canada, has ...
GlaxoSmithKline and Merck KGaA, Darmstadt, Germany have announced that they have entered into a global strategic allianc...
Venus Concept Ltd., an innovative global medical technology leader, announces the launch of its latest medical device, V...
Benjamin “Beno” Freedman, Ph.D., is named STEM CELLS’s Young Investigator of 2018 for his groundbreaki...
ProteoNic Biotechnology BV has announced that it licensed its 2G UNic technology for boosting recombinant protein produc...
Following a California Institute for Regenerative Medicine (CIRM) Independent Citizens Oversight Committee meeting held ...
OmniVision Technologies, Inc., a leading developer of advanced digital imaging solutions, along with SMARTmirror, a deve...
Senseonics Holdings, a medical technology company focused on the development and commercialization of a long-term, impla...
IQVIA has announced the launch of IQVIA Biotech and its new approach to delivering tailored clinical and commercial solu...
Torque, an immuno-oncology company developing first-in-class Deep Primed T Cell Therapeutics to direct immune power deep...
Biopharma company, Fortress Biotech dedicated to acquiring, developing and commercializing novel pharmaceutical and biot...
Cancer is far from an equal-opportunity killer. In 2018 - 18.1 million new cases developed worldwide, while around 9.6 m...
Alkermes plc has announced that it received a Complete Response Letter (CRL) from the U.S. Food and Drug Administration ...
Mylan has announced the U.S. Food and Drug Administration approval of Wixela Inhub (fluticasone propionate and salmetero...
